An aortic insufficiency diagnosed under cabergoline

被引:1
作者
Chague, F. [1 ]
Belleville, I. [3 ]
Boujon, B. [2 ]
Petit, J. -M. [3 ]
机构
[1] Hop Bocage, Ctr Explorat Font, F-21034 Dijon, France
[2] Hop Bocage, Ctr Cardiol, F-21034 Dijon, France
[3] Hop Bocage, Serv Endocrinol, F-21034 Dijon, France
来源
ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE | 2009年 / 58卷 / 03期
关键词
Cabergoline; Dopamine agonists; Valvulopathy; Hyperprolactinemia; VALVULAR HEART-DISEASE; DOPAMINE AGONISTS; PARKINSONS-DISEASE; VALVULOPATHY; PERGOLIDE;
D O I
10.1016/j.ancard.2008.05.022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report the case of a restrictive aortic insufficiency diagnosed on a 53-year old woman while being treated by low dose of cabergoline for hyperprolactinemia. Such valves involvements had already been described with cabergoline and other dopamine agonists, drugs the patient was previously exposed to. However, chronology of events leads US to Suspect cabergoline, although such effects had only been described with much higher doses. This case may recommend to perform echocardiograms Upon patients treated by cabergoline, and probably such it caution may be enforced in patients previously exposed to other dopamine agonists. On another hand, the diagnostic of a restrictive valvulopathy may lead to suspect a iatrogenic origin including dopamine agonists. (C) 2008 Elsevier Masson SAS. Tous droits reserves.
引用
收藏
页码:189 / 191
页数:3
相关论文
共 10 条
[1]  
Corvol JC, 2005, REV NEUROL-FRANCE, V161, P637
[2]   Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: A reader-blinded monocenter echocardiography study [J].
Junghanns, Susann ;
Fuhrmann, Joerg T. ;
Simonis, Gregor ;
Oelwein, Christian ;
Koch, Rainer ;
Strasser, Ruth H. ;
Reichmann, Heinz ;
Storch, Alexander .
MOVEMENT DISORDERS, 2007, 22 (02) :234-238
[3]   Focus on research - Drug and valvular heart disease [J].
Roth, Bryan L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (01) :6-9
[4]   Dopamine agonists and the risk of cardiac-valve regurgitation [J].
Schade, Rene ;
Andersohn, Frank ;
Suissa, Samy ;
Haverkamp, Wilhelm ;
Garbe, Edeltraut .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (01) :29-38
[5]  
Serratrice Jacques, 2002, Cardiol Rev, V10, P334, DOI 10.1097/00045415-200211000-00005
[6]   Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine [J].
Shively, BK ;
Roldan, CA ;
Gill, EA ;
Najarian, T ;
Loar, SB .
CIRCULATION, 1999, 100 (21) :2161-2167
[7]   Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease [J].
Van Camp, G ;
Flamez, A ;
Cosyns, B ;
Weytjens, C ;
Muyldermans, L ;
Van Zandijcke, M ;
De Sutter, J ;
Santens, P ;
Decoodt, P ;
Moerman, C ;
Schoors, D .
LANCET, 2004, 363 (9416) :1179-1183
[8]   Valvular heart disease in patients taking pergolide [J].
Waller, EA ;
Kaplan, J ;
Heckman, MG .
MAYO CLINIC PROCEEDINGS, 2005, 80 (08) :1016-1020
[9]   Dopamine agonists and cardiac valvulopathy in Parkinson disease - A case-control study [J].
Yamamoto, Mitsutoshi ;
Uesugi, Tadahisa ;
Nakayama, Takeo .
NEUROLOGY, 2006, 67 (07) :1225-1229
[10]   Valvular heart disease and the use of dopamine agonists for Parkinson's disease [J].
Zanettini, Renzo ;
Antonini, Angelo ;
Gatto, Gemma ;
Gentile, Rosa ;
Tesei, Silvana ;
Pezzoli, Gianni .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (01) :39-46